You are here: Industry Insights > Chikungunya

News List

Valneva’s chikungunya virus vaccine granted breakthrough designation pharmatimes
July 12, 2021
French speciality vaccine company Valneva has announced that its single-shot chikungunya vaccine candidate has received a breakthrough therapy designation from the US Food and Drug Administration (FDA).
Thermally stable chikungunya vaccine developed by researchers europeanpharmaceuticalreview
September 27, 2019
Researchers have developed a chikungunya vaccine that can be stored at warm temperatures and manufactured quickly, which has been validated in animal models.
Themis eyes phase 3 study for chikungunya vaccine after passing midstage test pharmatimes
November 09, 2018
There aren't any vaccines or treatments for the painful viral infection chikungunya, but with phase 2 results announced this week, Themis hopes it's one step closer to changing that.
Breakthrough research by scientists on Chikungunya virus biospectrum
September 28, 2018
Singapore scientists’ discovery could hold the key to novel treatments for the symptoms of mosquito-borne diseases
FDA places PaxVax's phase 2 Chikungunya shot on its 'fast track' fiercepharma
May 09, 2018
Working against a disease with no available vaccines, PaxVax has picked up an important regulatory boost from the FDA for its Chikungunya shot. The agency blessed the candidate with its Fast Track Designation...